CT
AZN icon

Cambridge Trust’s AstraZeneca AZN Stock Holding History

Cambridge Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$13.6K Hold
100
– – ﹤0.01% 557
2023
Q4 		$13.5K Hold
100
– – ﹤0.01% 552
2023
Q3 		$13.5K Hold
100
– – ﹤0.01% 544
2023
Q2 		$14.3K Hold
100
– – ﹤0.01% 562
2023
Q1 		$13.9K Hold
100
– – ﹤0.01% 595
2022
Q4 		$14K Hold
100
– – ﹤0.01% 597
2022
Q3 		$11K Hold
100
– – ﹤0.01% 629
2022
Q2 		$13K Sell
100
-154
-61% -$20.2K ﹤0.01% 651
2022
Q1 		$34K Sell
254
-15
-6% -$1.8K ﹤0.01% 590
2021
Q4 		$31K Buy
+269
New +$31.7K ﹤0.01% 610

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cambridge Trust's AZN Position: Q1 2024 in Review

Cambridge Trust held its AstraZeneca (AZN) position steady in Q1 2024 at 100 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #557.

Cambridge Trust first reported a position in AZN in Q4 2021 and has held it in 10 quarters since. The position peaked at $34K in Q1 2022. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • Cambridge Trust held 100 shares of AstraZeneca worth $13.6K as of Q1 2024.
  • Cambridge Trust left its AstraZeneca share count unchanged in Q1 2024.
  • AstraZeneca made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #557 holding.
  • Cambridge Trust first reported a position in AstraZeneca in Q4 2021 and has held it in 10 quarters since.
  • Cambridge Trust's AstraZeneca position peaked at $34K in Q1 2022.
  • 1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.